您的位置:首页--生工讲堂
8月27日美国Rensselaer Polytechnic Institute教授Mattheos Koffas学术报告
作者:黄春富 来源:生物工程学院 发布日期:2018-08-22 浏览次数:124

报告时间:2018-8-27上午10:00

报告地点:生物楼二楼报告厅

报告题目:基于生物合成高值化学品的大肠杆菌代谢工程和代谢流平衡

 

Engineering and balancing metabolic fluxes in E. coli for the biosynthesis of high value chemicals

 

Mattheos Koffas1,2,3

1 Dept. of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA

2 Dept. of Biological Sciences, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA

3 Center for Biotechnology and Interdisciplinary Sciences, Rensselaer Polytechnic Institute, Troy, NY, 12180, USA

 

 


A long theme in the field of metabolic engineering has been the identification of targets for genetic modifications in order to optimize cellular phenotypes, usually associated with the overproduction of a chemical of interest. In order to address this question and for the purpose of reprogramming the cellular network, we employ in silico model of the genome-wide metabolism in order to optimize the biosynthesis of high-value chemicals, such as phytochemicals, in E.coli. Such Systems Biology approaches, in combination with traditional genetic engineering have resulted in robust production levels that can result in the commercially viable processes for the synthesis of important molecules. However, often times, there is a need to further balance metabolic pathways in order to address the issue of metabolic burden, i.e. the draining of cellular resources in order to overexpress a recombinant pathway. Such metabolic pathway balancing has been achieved in our lab for the overproduction of chemicals that derive from long metabolic pathways, such as fatty acids, using episomal expression with vectors of different copy numbers, different strength promoters and different strength ribosome binding sites. It has also been achieved by engineering of feedback controls for dynamic tuning of metabolic fluxes around key intracellular metabolites, such as malonyl-CoA, using a dual transcriptional regulator. More recently, the use of synthetic microbial consortia has been employed to achieve metabolic balancing, opening up the possibility for the de novo production of a multitude of high-value chemicals.

 

[Mattheos Koffas教授简介] Mattheos Koffas is the Dorothy and Fred Chau ’71 Endowed Professor in the department of Chemical and Biological Engineering at Rensselaer Polytechnic Institute and the Career Development Professor of the Biocatalysis Constellation at Rensselaer Polytechnic Institute since 2011. He received his PhD from MIT in 2001 under the supervision of Professor Gregory Stephanopoulos where he worked on amino acid production from Corynebacterium glutamicum. He was a Visiting Research Scientist at DuPont Central Research from 2001 to 2002 where he worked on methanotrophic bacteria, resulting in nine patents. He works in the field of metabolic engineering and systems biotechnology with particular emphasis on the biosynthesis of natural products. He is the Editor of Biotechnology Advances and Metabolic Engineering Communications. He currently serves on the editorial board of several Journals, including the Current Opinion in Biotechnology, Metabolic Engineering, Biotechnology Journal, Biochemical Engineering Journal and Biotechnology and Bioprocess Engineering. He has published more than 80 peer review papers and holds a number of patents some of which have been commercialized. He was recently elected a fellow of the American Institute of Medical and Biological Engineering society.

 

欢迎光临!